Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Aenova is expanding its Bad Aibling site. With a total investment of around 20 million euros in new production and packaging lines, the site offers a modern, high-volume infrastructure for the production of effervescent products and blister packaging...
read more
Aenova announced the launch of its AenovationTM program. This program is designed to fast-track early development of pharmaceutical formulations, specifically addressing the critical challenges of bioavailability and time-to-market for poorly soluble...
read more
Aenova is expanding its site in Killorglin with a spray drying platform for amorphous solid dispersions (ASD) and inhalation powders. The brand-new laboratory- and pilot-scale equipment is aimed at developing formulations for innovative drug ...
read more
Thursday, October 04, 2012
Aenova, a leading provider of development and manufacturing services for medicines and dietary supplements has named Brad Carlson as its new Vice President of Marketing & Sales for the Americas, effective October 1, 2012. Mr. Carlson brings more ...
read more
Friday, February 12, 2021
Aerami has announced the signing of an exclusive license and development agreement with Hangzhou Chance to develop and commercialize Aerami’s drug device combination product candidate (AER-901).
read more
Wednesday, January 10, 2018
Aerie Pharmaceuticals announced the appointment of Julia Williams as Director of Medical Affairs, reporting to John Maltman, Ph.D., Aerie’s Vice President of Medical Affairs.
read more
Thursday, February 01, 2018
Aerie Pharmaceuticals has announced the appointment of Tad Heitmann as Head of Communications, reporting to Judith Robertson, Aerie’s Chief Commercial Officer.
read more
Monday, December 04, 2017
Aerie Pharmaceuticals announced the appointment of Heather Johnson as Regional Sales Director for the Northeast Region.
read more
Aerie Pharmaceuticals has received notification by its contract drug product manufacturer that the contract manufacturer has received a CRL from the FDA regarding the contract manufacturer’s NDA for one of their own product candidates.
read more
Wednesday, October 24, 2018
Aerie has built and commenced operation of its GMP-validated manufacturing facility for production of ophthalmic implants using the proprietary PRINT® Technology platform.
read more
Aerie Pharmaceuticals announced the appointment of Scott Laranjo as Director, Marketing, Roclatan, reporting to Deanne Melloy, Aerie’s Vice President of Marketing.
read more
Aerie Pharmaceuticals announced the appointment of Concetta Perro as Commercial Counsel, reporting to John LaRocca, Aerie’s General Counsel.
read more
Monday, November 27, 2017
Aerie Pharmaceuticals announced the appointment of Nhi Ong as Director of Analytics.
read more
Aerie Pharmaceuticals has acquired from Envisia Therapeutics the rights to use PRINT technology in ophthalmology and certain other assets.
read more
Wednesday, September 20, 2017
Jacobs has been selected by Aerie to provide EPCM for Aerie’s first pharmaceutical manufacturing facility, located in the IDA’s advanced technology building in Athlone, Ireland.
read more